Seneca Capital Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Seneca Capital Investments’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-36,500	Closed	-$6.31M	–	61
2015 Q1	$6.31M	Buy	+36,500	New	+$5.36M	1.44%	27

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Seneca Capital Investments's SLXP Position: Q2 2015 in Review

Seneca Capital Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 36,500 shares — an estimated $6.31M sold.

Seneca Capital Investments first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $6.31M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Seneca Capital Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Seneca Capital Investments sold 36,500 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.31M.
Seneca Capital Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Seneca Capital Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $6.31M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Seneca Capital Investments's 13F filing for Q2 2015, filed 14 Aug 2015.